Atlas Trials

Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia

Clinical trial NCT05018936 · WITHDRAWN

Trial details

NCT number
NCT05018936
Sponsor
Peking Union Medical College Hospital
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Aplastic AnemiaDrug Effect
Start date
2021-10-01
Primary completion
2023-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.